- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x V54: 7-{[3-({[(6-aminopyridin-2-yl)methyl]amino}methyl)phenoxy]methyl}quinolin-2-amine(Non-covalent)
V54.2: 12 residues within 4Å:- Chain A: I.218, F.235, W.238, Y.239, M.240, E.243, R.247, T.328, W.329
- Chain B: F.342
- Ligands: HEM.1, PEG.15
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.218, A:I.218, A:F.235, B:F.342
- Hydrogen bonds: A:M.240, A:E.243, A:R.247, A:T.328
- Water bridges: A:R.247
- pi-Stacking: A:W.329, A:W.329, A:W.329
V54.10: 12 residues within 4Å:- Chain A: F.342
- Chain B: I.218, F.235, W.238, Y.239, M.240, E.243, R.247, T.328, W.329
- Ligands: PEG.7, HEM.9
12 PLIP interactions:11 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.218, B:I.218, B:F.235, A:F.342
- Hydrogen bonds: B:M.240, B:E.243, B:R.247, B:T.328
- Water bridges: B:R.247
- pi-Stacking: B:W.329, B:W.329, B:W.329
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 6 residues within 4Å:- Chain A: R.65, M.221, Y.355, F.356, Y.357
- Ligands: HEM.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.65, A:Y.357
GOL.5: 4 residues within 4Å:- Chain A: E.224, H.229, K.352, F.356
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.229, A:K.352
GOL.6: 3 residues within 4Å:- Chain A: W.238, S.298, I.299
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.298, A:I.299
GOL.12: 6 residues within 4Å:- Chain B: R.65, M.221, Y.355, F.356, Y.357
- Ligands: HEM.9
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.65, B:Y.357
GOL.13: 4 residues within 4Å:- Chain B: E.224, H.229, K.352, F.356
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.229, B:K.352
GOL.14: 3 residues within 4Å:- Chain B: W.238, S.298, I.299
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.298, B:I.299
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.7: 6 residues within 4Å:- Chain A: W.327, S.345
- Chain B: R.65, T.328, W.329
- Ligands: V54.10
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.328
- Water bridges: B:R.65
PEG.15: 6 residues within 4Å:- Chain A: R.65, T.328, W.329
- Chain B: W.327, S.345
- Ligands: V54.2
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.328
- Water bridges: A:R.65
- 2 x POL: N-PROPANOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, M.C. et al., Selective Anti-MRSA inhibitors targeting Nitric Oxide Synthase. To Be Published
- Release Date
- 2021-06-30
- Peptides
- Nitric oxide synthase oxygenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
SMTL ID : 6xk8.1
Structure of Bacillus subtilis Nitric Oxide Synthase in complex with 7-((3-((((6-aminopyridin-2-yl)methyl)amino)methyl)phenoxy)methyl)quinolin-2-amine
Nitric oxide synthase oxygenase
Toggle Identical (AB)Related Entries With Identical Sequence
4d3i.1 | 4d3j.1 | 4d3k.1 | 4d3m.1 | 4d3n.1 | 4d3o.1 | 4d3t.1 | 4d7h.1 | 4d7j.1 | 4lwa.1 | 4lwa.2 | 4lwb.1 | 4lwb.2 | 4ug5.1 | 4ug6.1 | 4ug7.1 | 4ug8.1 | 4ug9.1 | 4uga.1 | 4ugb.1 | 4ugc.1 | 4ugd.1 | 4uge.1 | 4ugf.1 | 4ugg.1 | 4ugh.1 | 4ugi.1 | 4ugj.1 | 4ugk.1 | 4ugl.1 more...less...4ugm.1 | 4ugn.1 | 4ugo.1 | 4ugp.1 | 4ugq.1 | 4ugr.1 | 4ugs.1 | 4ugt.1 | 4ugu.1 | 4ugx.1 | 4ugy.1 | 4uqr.1 | 4uqs.1 | 5g65.1 | 5g66.1 | 5g67.1 | 5g68.1 | 5g69.1 | 5g6a.1 | 5g6b.1 | 5g6d.1 | 5g6e.1 | 5g6f.1 | 5g6g.1 | 5g6h.1 | 5g6j.1 | 5g6l.1 | 5g6m.1 | 5g6n.1 | 5g6o.1 | 5g6q.1 | 6xcx.1 | 6xk3.1 | 6xk4.1 | 6xk5.1 | 6xk6.1 | 6xk7.1 | 6xmc.1